{"nct_id":"NCT02336451","title":"A Phase II Study to Evaluate the Efficacy and Safety of Oral Ceritinib in Patients With ALK-positive NSCLC Metastatic to the Brain and/or to Leptomeninges","status":"COMPLETED","status_verified_date":"2020-04","start_date":"2015-04-01","start_date_type":"ACTUAL","primary_completion_date":"2019-02-06","primary_completion_date_type":"ACTUAL","completion_date":"2019-02-06","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}